KonstantinidesSV, MeyerG, BecattiniC. ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J2019;2020:543–603.
3.
INSPIRATION Investigators, SadeghipourP, TalasazAH, . Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. JAMA2021;325:1620–30.doi:10.1001/jama.2021.4152http://www.ncbi.nlm.nih.gov/pubmed/33734299
4.
ChatterjeeS, ChakrabortyA, WeinbergI, . Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA2014;311:2414–21.doi:10.1001/jama.2014.5990http://www.ncbi.nlm.nih.gov/pubmed/24938564
5.
PiazzaG. Advanced management of intermediate- and high-risk pulmonary embolism: JACC focus seminar. J Am Coll Cardiol2020;76:2117–27.doi:10.1016/j.jacc.2020.05.028http://www.ncbi.nlm.nih.gov/pubmed/33121720
6.
MeyerG, VicautE, DanaysT, . Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med2014;370:1402–11.doi:10.1056/NEJMoa1302097http://www.ncbi.nlm.nih.gov/pubmed/24716681
7.
RothschildDP, GoldsteinJA, BowersTR. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: clinical efficacy but attendant hemorrhagic risks. Catheter Cardiovasc Interv2019;93:506–10.doi:Alteplasehttp://www.ncbi.nlm.nih.gov/pubmed/30549393
8.
SharifiM, BayC, SkrockiL, . Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol2013;111:273–7.doi:10.1016/j.amjcard.2012.09.027http://www.ncbi.nlm.nih.gov/pubmed/23102885
9.
GünerA, KalçikM, AykanAhmet Ç, . Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism. Blood Coagul Fibrinolysis2020;31:536–42.doi:10.1097/MBC.0000000000000960http://www.ncbi.nlm.nih.gov/pubmed/33181758
